2026. January 17., Saturday
Szegedi Tudományegyetem Szent-Györgyi Albert Orvostudományi Kar

University of Szeged
Albert Szent-Györgyi Medical School
 
Foreign Students' Secretariat




Your Education. Our Mission.

telegdy

In memoriam of Prof. Dr. Gyula Telegdy

Prof. Dr. Gyula Telegdy was born on 5 June 1935 in Sibiu (Romania). During his career, he worked as a neuroendocrinologist, clinician, teaching physician and researcher. Between 1992 and 1995 he was President of the Hungarian Society for Endocrinology, and between 1993 and 1998 he was Vice-President of the Hungarian Physiological Society.

He received his medical degree from the Medical University of Pécs in 1959. After graduation, he worked at the Department of Physiology at the same university. In 1964 he was awarded a Lalor Fellowship and subsequently spent 2 years as a researcher in the United States of America. Between 1968 and 1971, his research was supported by the Ford Foundation at the Karolinska Institute in Stockholm. In 1975, he was appointed Head of Department at the Department of Pathophysiology, Albert Szent-Györgyi Medical University in Szeged. He held this position for 25 years. For a long time, he was also head of the Neurohumoral Regulations Research Group, a joint research group of the University and the Hungarian Academy of Sciences. During his tenure as Dean, he contributed to the introduction of the English Programme in Szeged, which allowed foreign students to study Medicine at the faculty. After 2005, he continued to work as Professor Emeritus at the Department of Pathophysiology.


His main area of research was neuroendocrinology. Among other things, he has shown that the fetus and placenta act as one single unit, the fetoplacental unit and that the hypothalamic-pituitary-adrenal axis is regulated by several neuropeptides. In 2004, he was awarded the Commander’s Cross of the Hungarian Order of Merit, in 2006 he was made an honorary citizen of Szeged, and in 2020 he became the first person to receive the Pro Scientia Lifetime Achievement Award of the Szeged Regional Committee of the Hungarian Academy of Sciences.


In his field of research, he has built an extensive network of national and international cooperation. Prof. Dr. Gyula Telegdy is the author of nearly 500 scientific publications in English and 35 in Hungarian, as well as 2 books. His work as an educator was exemplary. Three of his students became full members of the Hungarian Academy of Sciences, while 2 others became doctors of the same institution. Under his supervision and guidance, 26 researchers have received their PhD degrees. Prof. Telegdy was highly respected by his colleagues and they are still grateful to him for his assistance.


Professor Telegdy lived for his work, but always spoke proudly of his family.


Rest in peace, Professor Telegdy.

Latest news

molnar_jozsef_prof

It is with shock and sincere sorrow that we bid farewell to Professor Emeritus József Molnár, who passed away quietly at the age of 89.

ciklotron_s_136

Following a cornerstone-laying ceremony for SZTE’S Regional Cyclotron and Radiopharmaceutical Supply Center in April, another major milestone has been reached in one of the University of Szeged’s flagship strategic investments. On December 9, GE HealthCare announced that – for the first time worldwide – the MINItrace Magni cyclotron will be installed at the University of Szeged, marking a major advance for nuclear medicine and theranostic treatment in Hungary. At a special event held at the University’s main building, the significance and future impact of the pioneering device were outlined by Prof. Dr. László Rovó, Rector of the University of Szeged; Dr. Judit Fendler, Chancellor; Prof. Dr. László Pávics, Professor at the Institute of Nuclear Medicine and project leader; Dr. György Erőss, Regional Customer Relations Manager for Central and Eastern Europe at GE HealthCare Hungary Kft.; and Jan Wolber, Global Product Leader for GE HealthCare Digital.

kja___number_2870

 

The University of Szeged has inaugurated its Human Kinesiology Laboratory, where cutting-edge robotic technologies are being deployed to enhance the effectiveness of rehabilitation therapies and actively support patients throughout their recovery process.